Detailed Information on Publication Record
2021
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
HOENIGL, M., J. SALMANTON-GARCIA, T. J. WALSH, M. NUCCI, C. F. NEOH et. al.Basic information
Original name
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
Authors
HOENIGL, M. (guarantor), J. SALMANTON-GARCIA, T. J. WALSH, M. NUCCI, C. F. NEOH, J. D. JENKS, M. LACKNER, R. SPRUTE, A. M. S. AL-HATMI, M. BASSETTI, F. CARLESSE, Tomáš FREIBERGER (203 Czech Republic, belonging to the institution), P. KOEHLER, T. LEHRNBECHER, A. KUMAR, J. PRATTES, M. RICHARDSON, S. REVANKAR, M. A. SLAVIN, J. STEMLER, B. SPIESS, S. J. TAJ-ALDEEN, A. WARRIS, P. C. Y. WOO, J. A. H. YOUNG, K. ALBUS, D. ARENZ, V. ARSIC-ARSENIJEVIC, J. P. BOUCHARA, T. R. CHINNIAH, A. CHOWDHARY, G. S. DE HOOG, G. DIMOPOULOS, R. F. DUARTE, P. HAMAL, J. F. MEIS, S. MFINANGA, F. QUEIROZ-TELLES, T. F. PATTERSON, G. RAHAV, T. R. ROGERS, C. ROTSTEIN, R. WAHYUNINGSIH, D. SEIDEL and O. A. CORNELY
Edition
Lancet Infectious Diseases, Oxford, Elsevier SCI LTD, 2021, 1473-3099
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30303 Infectious Diseases
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 71.421
RIV identification code
RIV/00216224:14110/21:00123978
Organization unit
Faculty of Medicine
UT WoS
000680046200004
Keywords in English
rare mould infections; diagnosis; management
Tags
International impact, Reviewed
Změněno: 29/3/2022 12:42, Mgr. Tereza Miškechová
Abstract
V originále
With increasing numbers of patients needing intensive care or who are immunosuppressed, infections caused by moulds other than Aspergillus spp or Mucorales are increasing. Although antifungal prophylaxis has shown effectiveness in preventing many invasive fungal infections, selective pressure has caused an increase of breakthrough infections caused by Fusarium, Lomentospora, and Scedosporium species, as well as by dematiaceous moulds, Rasamsonia, Schizophyllum, Scopulariopsis, Paecilomyces, Penicillium, Talaromyces and Purpureocillium species. Guidance on the complex multidisciplinary management of infections caused by these pathogens has the potential to improve prognosis. Management routes depend on the availability of diagnostic and therapeutic options. The present recommendations are part of the One World-One Guideline initiative to incorporate regional differences in the epidemiology and management of rare mould infections. Experts from 24 countries contributed their knowledge and analysed published evidence on the diagnosis and treatment of rare mould infections. This consensus document intends to provide practical guidance in clinical decision making by engaging physicians and scientists involved in various aspects of clinical management. Moreover, we identify areas of uncertainty and constraints in optimising this management.